19 studies found for:    Open Studies | estrogen replacement therapy
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Conditions: Endometrial Hyperplasia;   Endometrial Cancer
Interventions: Drug: progesterone;   Drug: activella
2 Unknown  Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
Conditions: Menopause, Premature;   Hysterectomy;   Ovariectomy;   Estrogen Replacement Therapy;   Attitude;   Perception
Intervention: Procedure: Hysterectomy and Bilateral salpingo-oophorectomy
3 Recruiting Perimenopausal Effects of Estradiol on Reward Responsiveness
Condition: Perimenopausal Depression
Interventions: Drug: Estradiol;   Drug: Progesterone
4 Not yet recruiting Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen
Conditions: Pelvic Organ Prolapse;   Urogenital Prolapse;   Vaginal Vault Prolapse;   Cystocele;   Uterine Prolapse;   Vaginal Prolapse;   Pelvic Floor Disorders
Interventions: Drug: Conjugated Estrogens Cream;   Drug: Placebo Cream
5 Unknown  Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
Conditions: Hypogonadism;   Opioid-Related Disorders;   Male Infertility
Interventions: Drug: Clomiphene citrate;   Drug: Placebo
6 Recruiting Estrogen Diastolic Heart Failure
Condition: Menopause
Interventions: Drug: Estradiol/Norethindrone acetate;   Drug: Placebo
7 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Monthly Administration of Somavaratan in Adults With GHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
8 Recruiting Versartis International Trial in Adults With Long-Acting Growth Hormone
Condition: Adult Growth Hormone Deficiency
Intervention: Drug: somavaratan
9 Recruiting Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy
Condition: Menopausal Syndrome
Interventions: Drug: Micronized estradiol + progesterone;   Drug: Nanoparticulate estradiol + progesterone
10 Unknown  A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET
Condition: Infertility
Interventions: Other: natural cycles;   Drug: estradiol and progesterone
11 Recruiting HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Conditions: Infertility;   Polycystic Ovarian Syndrome
Interventions: Drug: Estradiol valerate;   Drug: Sequential Clomiphene citrate and Gonadotropin
12 Recruiting HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients
Condition: Infertility
Interventions: Drug: Estradiol valerate;   Drug: Sequential Clomiphene citrate and Gonadotropin
13 Unknown  Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients
Condition: Infertility
Interventions: Other: observation natural cycle;   Drug: Agonist GnRH; estradiol Valerate; progesterone
14 Unknown  Effects of Estradiol on Menopausal Breast
Condition: Hormone Replacement Therapy
Intervention: Drug: Angemin vs Activelle
15 Unknown  The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles
Condition: Infertility
Interventions: Drug: Letrozole and human chorionic gonadotrophin;   Drug: estradiol and progesterone
16 Unknown  Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles
Condition: Infertility
Interventions: Biological: frozen Embryo transfer;   Drug: 10,000U hCG injection;   Drug: GnRH agonist (Superfact);   Drug: administration of 6 mg Estradiol valerate
17 Unknown  Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Conditions: Menopausal Syndrome;   Cardiovascular Disease;   Osteoporosis;   Breast Cancer
Interventions: Drug: estradiol plus MPA;   Drug: Ximingting Tablet;   Drug: estradiol plus progesterone
18 Recruiting Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
Conditions: Venous Thrombosis;   Insulin Resistance
Interventions: Drug: Femoston Conti;   Drug: EVOREL® CONTI
19 Unknown  Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
Conditions: Physiological Processes [G07.700];   Aging [G07.700.320.124];   Exercise [G11.427.590.530.698.277]
Interventions: Drug: Transdermal estradiol;   Drug: Estradiol plus progesterone;   Drug: Oral Progesterone;   Drug: Placebo

Indicates status has not been verified in more than two years